7Bontenbal M, Andersson M, Wildiers J, et al. Doxorubicin vs epirubicin, report of a second-line randomized phase Ⅱ/Ⅲ study in advanced breast cancer [ J ]. Br J Cancer, 1998,77 ( 12 ) : 2257 - 2263.
8Nabhohz JM, Senn HJ, Bezwoda WR, et al. Prospective ran- domized trial of docetaxel versus mitumyein plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy[ J]. J Clin Oncol, 1999, 17(5) :1413 - 1424.
9Venturini M, paridaens R, Rossner D, et al. An open-label, multi- center study of outpatient capecitabine monotherapy in 631 pa- tients with pretreated advanced breast cancer [ J ]. Ontology, 2007.72(1) : 51 -57.
10Nabholtz JM,Falkson C,Campos D,et al. Docetaxel and doxoru- bicin compared with doxorubiein and eyclophosphamid as first- line chemotherapy for metastatic breast caneer: results of a ran- doinized,multicenter,phase Ⅲ trial [ J ]. J Clin Oncol,2003,21 (6) :968 -975.
